AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM ODEA R MURRAY DC BARRE PE
Citation: Rn. Foley et al., MODE OF DIALYSIS THERAPY AND MORTALITY IN END-STAGE RENAL-DISEASE, Journal of the American Society of Nephrology, 9(2), 1998, pp. 267-276
LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS
Authors: FOLEY RN PARFREY PS KENT GM HARNETT JD MURRAY DC BARRE PE
Citation: Rn. Foley et al., LONG-TERM EVOLUTION OF CARDIOMYOPATHY IN DIALYSIS PATIENTS, Kidney international, 54(5), 1998, pp. 1720-1725
MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., MORTALITY IN ESRD - THE RESCUE EFFECT OF SWITCHING FROM PD TO HEMODIALYSIS, Journal of the American Society of Nephrology, 8, 1997, pp. 1007-1007
CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE
Authors: FOLEY RN CULLETON BF PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., CARDIAC DISEASE IN DIABETIC END-STAGE RENAL-DISEASE, Diabetologia, 40(11), 1997, pp. 1307-1312
CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD
Authors: CULLETON BF FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Bf. Culleton et al., CARDIAC DISEASE IN DIABETIC-PATIENTS WITH ESRD, Journal of the American Society of Nephrology, 7(9), 1996, pp. 977-977
MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., MODE OF DIALYSIS, CARDIAC MORBIDITY AND MORTALITY IN ESRD, Journal of the American Society of Nephrology, 7(9), 1996, pp. 993-993
HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE, Journal of the American Society of Nephrology, 7(5), 1996, pp. 728-736
OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA
Authors: PARFREY PS FOLEY RN HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Ps. Parfrey et al., OUTCOME AND RISK-FACTORS FOR LEFT-VENTRICULAR DISORDERS IN CHRONIC UREMIA, Nephrology, dialysis, transplantation, 11(7), 1996, pp. 1277-1285
THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., THE IMPACT OF ANEMIA ON CARDIOMYOPATHY, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE, American journal of kidney diseases, 28(1), 1996, pp. 53-61
HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM HU LQ ODEA R MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPOCALCEMIA, MORBIDITY, AND MORTALITY IN END-STAGE RENAL-DISEASE, American journal of nephrology, 16(5), 1996, pp. 386-393
IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., IMPACT OF HYPERTENSION ON CARDIOMYOPATHY, MORBIDITY AND MORTALITY IN END-STAGE RENAL-DISEASE, Kidney international, 49(5), 1996, pp. 1379-1385
OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA
Authors: PARFREY PS FOLEY RN HARNETT JD KENT GM MURRAY D BARRE PE
Citation: Ps. Parfrey et al., OUTCOME AND RISK-FACTORS OF ISCHEMIC-HEART-DISEASE IN CHRONIC UREMIA, Kidney international, 49(5), 1996, pp. 1428-1434
HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPOALBUMINEMIA - A MAJOR RISK FACTOR FOR CARDIAC DISEASE IN ESRD, Journal of the American Society of Nephrology, 6(3), 1995, pp. 529-529
HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., HYPERTENSION, CARDIOMYOPATHY, CARDIAC MORBIDITY AND MORTALITY IN ESRD, Journal of the American Society of Nephrology, 6(3), 1995, pp. 529-529
CARDIAC DISEASE IN END-STAGE RENAL-DISEASE - A COMPARISON OF HEMODIALYSIS (HD) AND PERITONEAL-DIALYSIS (PD)
Authors: HARNETT JD KENT G FOLEY R MURRAY D BARRE P PARFREY P
Citation: Jd. Harnett et al., CARDIAC DISEASE IN END-STAGE RENAL-DISEASE - A COMPARISON OF HEMODIALYSIS (HD) AND PERITONEAL-DIALYSIS (PD), Journal of the American Society of Nephrology, 6(3), 1995, pp. 532-532
THE NATURAL-HISTORY OF UREMIC CARDIOMYOPATHY
Authors: PARFREY PS HARNETT JD KENT GM ODEA R MURRAY D BARRE PE
Citation: Ps. Parfrey et al., THE NATURAL-HISTORY OF UREMIC CARDIOMYOPATHY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 555-555
THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., THE PROGNOSTIC IMPORTANCE OF LEFT-VENTRICULAR GEOMETRY IN UREMIC CARDIOMYOPATHY, Journal of the American Society of Nephrology, 5(12), 1995, pp. 2024-2031
WHAT IS THE BEST APPROACH TO ASYMPTOMATIC CORONARY-ARTERY DISEASE IN DIALYSIS PATIENTS SEEKING TRANSPLANTATION
Authors: CULLETON BF HARNETT JD
Citation: Bf. Culleton et Jd. Harnett, WHAT IS THE BEST APPROACH TO ASYMPTOMATIC CORONARY-ARTERY DISEASE IN DIALYSIS PATIENTS SEEKING TRANSPLANTATION, Seminars in dialysis, 8(4), 1995, pp. 208-209
CARDIAC-FUNCTION AND HEMATOCRIT LEVEL
Authors: HARNETT JD KENT GM FOLEY RN PARFREY PS
Citation: Jd. Harnett et al., CARDIAC-FUNCTION AND HEMATOCRIT LEVEL, American journal of kidney diseases, 25(4), 1995, pp. 3-7
CONGESTIVE-HEART-FAILURE IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, PROGNOSIS AND RISK-FACTORS
Authors: HARNETT JD FOLEY RN KENT GM BARRE PE MURRAY D PARFREY PS
Citation: Jd. Harnett et al., CONGESTIVE-HEART-FAILURE IN DIALYSIS PATIENTS - PREVALENCE, INCIDENCE, PROGNOSIS AND RISK-FACTORS, Kidney international, 47(3), 1995, pp. 884-890
CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGERENAL-DISEASE THERAPY
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MARTIN CJ MURRAY DC BARRE PE
Citation: Rn. Foley et al., CLINICAL AND ECHOCARDIOGRAPHIC DISEASE IN PATIENTS STARTING END-STAGERENAL-DISEASE THERAPY, Kidney international, 47(1), 1995, pp. 186-192
IMPACT OF RENAL-TRANSPLANTATION ON UREMIC CARDIOMYOPATHY
Authors: PARFREY PS HARNETT JD FOLEY RN KENT GM MURRAY DC BARRE PE GUTTMANN RD
Citation: Ps. Parfrey et al., IMPACT OF RENAL-TRANSPLANTATION ON UREMIC CARDIOMYOPATHY, Transplantation, 60(9), 1995, pp. 908-914
CHRONIC HYPOCALCEMIA - A MAJOR MORBIDITY AND MORTALITY FACTOR IN ESRDPATIENTS
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM HU LQ MURRAY DC BARRE PE
Citation: Rn. Foley et al., CHRONIC HYPOCALCEMIA - A MAJOR MORBIDITY AND MORTALITY FACTOR IN ESRDPATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 446-446
LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS
Authors: FOLEY RN PARFREY PS HARNETT JD KENT GM MURRAY DC BARRE PE
Citation: Rn. Foley et al., LEFT-VENTRICULAR (LV) GEOMETRY - A CRITICAL PROGNOSTIC VARIABLE IN ESRD PATIENTS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 446-446
ISCHEMIC-HEART-DISEASE IN ESRD - PREVALENCE, PROGNOSIS AND RISK-FACTORS
Authors: HARNETT JD PARFREY PS FOLEY RN KENT GM HU LQ ODEA R MURRAY DC BARRE PE
Citation: Jd. Harnett et al., ISCHEMIC-HEART-DISEASE IN ESRD - PREVALENCE, PROGNOSIS AND RISK-FACTORS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 452-452
Risultati: 1-25 | 26-35